Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Study ID: NCT04172779
Start Date: 2025-07
End Date: 2030-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Erlotinib Hydrochloride

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Motor Recovery Through Plasticity-Inducing Cortical Stimulation

Study ID: NCT06506279
Start Date: 2025-07-01
End Date: 2030-06-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4

Intervention / Treatment

CorTec Brain Interchange (BIC) System

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Enhancing Veteran-Clinical Collaboration in VA PRRCs

Study ID: NCT06898879
Start Date: 2026-01-01
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

119

Intervention / Treatment

Collaborative Decision Skills Training

Leveling Up

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Usability of Pericardial Flushing with the Haermonics Pure System After Cardiac Surgery

Study ID: NCT06521164
Start Date: 2025-10-01
End Date: 2026-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

65

Intervention / Treatment

Haermonics Pure system

Sponsor

Haermonics BV

Source: clinicaltrials.gov

Share:
Add to list

Outpatient Floor Pedal Bike Utilization

Study ID: NCT06586190
Start Date: 2025-08
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Floor Pedal Bike with Guided Instructions for Home

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

Study ID: NCT06866964
Start Date: 2025-07
End Date: 2031-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Low-dose ASA

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis

Study ID: NCT06916390
Start Date: 2025-09-30
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

20

Intervention / Treatment

Guselkumab

Diet

Sponsor

University hospitals KU Leuven

Source: clinicaltrials.gov

Share:
Add to list

Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia

Study ID: NCT06769490
Start Date: 2025-06-30
End Date: 2030-09-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

44

Intervention / Treatment

Ziftomen's

Quizzard

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue

Study ID: NCT06505590
Start Date: 2025-09
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

372

Intervention / Treatment

Educational content

Educational material plus self-management program - self-administered version

Educational material plus self-management program - guided version with mental health professional

Sponsor

Gustave Roussy, Campus Cancer, Grand Paris

Source: clinicaltrials.gov

Share:
Add to list

The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients

Study ID: NCT03116490
Start Date: 2026-01-16
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Anesthesia type

Sponsor

Wenzhou Medical University

Source: clinicaltrials.gov

Share:
Add to list